The development history of leading enterprises in the medical information industry has been more than ten years, and it has initially achieved the leading position in the market control and technology products. The radiation coverage of the country is not within the local leadership in the short term. Therefore, in the process of building a large healthy environment to grab land, the national leading enterprises are bound to further open the gap. On June 24, 2016, with the approval of Premier Li Keqiang, the General Office of the State Council issued the “Guiding Opinions on Promoting and Regulating the Development of Big Data Applications for Health Care â€, giving the industry another shot of strength. In terms of operational ideas, enterprises choose the corresponding path according to their previous resource advantages (technical, commercial, government, etc.), and are divided into two main operating lines: hospital (large health) and regional (regional platform operation). Representative enterprises have emerged. Although the business model is not the same, but the purpose is the same, that is, cut into the business process to participate in operations to earn service fees, become a large platform for the industry chain. In time, the overall planning of the two paths takes a long time to complete, and future investment will be carried out around the fulfillment ability. Enterprises with staged results are more worthy of attention, such as Weining Health, Sitron Medical, and entrepreneurial software. Wanda Information and so on. Commercial health insurance growth enhances market space, interest binding and boost business model The industry's gratifying changes: In 2015, commercial health insurance revenue was 241 billion. At the same time of high-speed growth of 52% (faster than 14-year growth rate), the concentration of the industry remained at a high level. Life insurance accounted for 19%, personal insurance 8%, and safety. Close to 20%. The national medical reform has carried out comprehensive pilot projects in 11 provinces, the coverage is still expanding, the comprehensive coverage policy of major medical insurance is warming up, and the bidding of the custody business insurance is coming to an end, and the high concentration is convenient for manufacturers to compete for the market. Recently, a number of control manufacturers and social security related companies and insurance companies have strengthened cooperation (capital level), and these manufacturers are expected to grasp the early advantages in terms of future market share. As the actual payment side of China's medical industry , medical insurance, its growth rate directly determines the market space of the health industry, especially the future income of some information technology manufacturers. The current high growth trend of commercial insurance is expected to give the industry a greater affirmation and give the listed company full confidence. Such as: Wei Ning health and so on. High valuation and company performance The overall trend of medical informatization is to continue to rise, and there is space or structural shift (the first-line manufacturers have a large lead and both have extended strategies). At present, the valuation of companies in the industry is generally more expensive. The company's performance reflects the progress, not the main reason for the contribution of market value. The market value includes a large expectation for new business and new business models in the future. At present, the performance of the company is mainly based on traditional software sales. The new business still needs time to produce results. Although the valuation is relatively expensive, the market demand is relatively rigid, and the traditional business can still maintain a good growth trend. Some manufacturers in the industry develop new business. The progress is basically in line with expectations. From the perspective of performance contribution, time is expected to be as early as this year. risk warning There is uncertainty in the cooperation model between medical informatization manufacturers and commercial insurance companies; in the process of building a large healthy ecological environment, the corresponding companies need long-term investment; there is uncertainty in the time period from the promotion of relevant policies to the landing of industrial big data applications. Butyl Rubber Stopper For Antibiotic Bottle Our butyl rubber stoppers for antibiotic bottles are produced by a series of advanced technics during the production such as vulcanization, mould cutting, washing and packaging .These procedures are set due to the GMP standard. Also we have a full set of quality control system which ensures us to offer suitable products at best prices.After the goods are finished, we will use a full automatic washing line to clean the goods, and our washing line has a powerful vibrating and wash-blowing fuction. Our products have a good compability with drugs. If you are looking for an excellent and loyal cooperator , pls feel free to contact us. Butyl Rubber Stopper For Antibiotic Bottle,Rubber Stopper,Stopper For Antibiotic Bottle,Sterilized Butyl Rubber Stoppers SUZHOU CRH PHARMACEUTICAL TECHNOLOGY CO.,LTD , https://www.crh-health.com